Eye scan tips for MS: Which retinal measure is more reliable

Credibility

Interest

Key Takeaway

Careful quality checks matter: macular (GCIPL) thickness readings stay reliable even when some scan problems occur, but pRNFL (optic nerve) readings get less reliable if scans fail OSCAR-IB quality checks.

What They Found

Researchers compared two eye scan types used to spot one-sided optic nerve problems: pRNFL (around the optic nerve) and GCIPL (in the macula). They sorted scans into those that passed all OSCAR-IB quality checks and those that failed one or more checks, then re-scanned each eye the same day to see how consistent the numbers were. Macular GCIPL thickness was very consistent whether scans passed or failed the checks, meaning small scan problems had little effect on these results. pRNFL thickness was much less consistent when scans failed the OSCAR-IB checks, so mistakes or poor-quality scans made those numbers less trustworthy. The biggest causes of poor reproducibility were algorithm failure for pRNFL and low image signal for GCIPL, showing different weaknesses for the two measurements.

Who Should Care and Why

People with MS and their caregivers should care because these eye scans help doctors find one-sided optic nerve damage, which can affect diagnosis, monitoring, and treatment choices. If a pRNFL scan has quality issues, it might wrongly suggest or miss optic nerve involvement — like using a blurry photo to decide if a car has a dent. Clinic staff and neurologists should use OSCAR-IB quality checks for pRNFL scans to avoid wrong conclusions, while GCIPL scans appear more forgiving of minor problems. Patients preparing for scans can help by keeping still and asking for a repeat if the technician says the image quality is low, similar to retaking a blurry photo. Overall, this means GCIPL results might be more trustworthy in some situations, but quality control is still important for accurate care.

Important Considerations

This study used one OCT machine model (Spectralis) so results might differ with other machines or older devices. Scans were repeated during the same visit, so we don’t know how well measurements hold up over months or years. Also, the study focused on technical reliability (consistency), not on whether the measurements changed with actual disease activity, so clinical decisions should still combine scans with symptoms and other tests.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics Specific Symptoms Clinical Trials

Article Topics:

OCTOSCAR-IB criteriainter-eye differencemultiple sclerosisreliabilitytest-retest

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News